Evoke Pharma (EVOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,156 | 24,197 | 116 | 866 | N/A |
| Other current assets | 138 | 0 | 0 | 0 | 0 |
| TOTAL | $15,225 | $24,431 | $116 | $905 | $N/A |
| Non-Current Assets | |||||
| Other Non-Current Assets | 8 | 556 | 0 | 0 | 0 |
| TOTAL | $8 | $556 | $N/A | $N/A | $N/A |
| Total Assets | $15,233 | $24,987 | $116 | $905 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 127 | 1,443 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,012 | 285 | 97 | 89 | 0 |
| Accrued Expenses | 697 | 557 | 418 | 207 | N/A |
| Other current liabilities | 12 | N/A | 56 | 39 | N/A |
| TOTAL | $1,848 | $2,285 | $570 | $335 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,196 | 1,512 | 980 | N/A | N/A |
| Other Non-Current Liabilities | 0 | 7 | 0 | 0 | 0 |
| TOTAL | $4,196 | $1,518 | $980 | $N/A | $N/A |
| Total Liabilities | $6,044 | $3,803 | $1,550 | $335 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43 | 42 | N/A | N/A | N/A |
| Common Shares | 1 | 1 | 0 | 0 | N/A |
| Retained earnings | -35,939 | -22,692 | -19,855 | -17,838 | N/A |
| Other shareholders' equity | 0 | 0 | 18,225 | 18,225 | 0 |
| TOTAL | $9,189 | $21,183 | $-1,434 | $571 | $N/A |
| Total Liabilities And Equity | $15,233 | $24,987 | $116 | $905 | $0 |